Ascentage Pharma Group In... (AAPG)
NASDAQ: AAPG
· Real-Time Price · USD
25.17
-0.31 (-1.22%)
At close: May 05, 2025, 3:59 PM
25.30
0.52%
After-hours: May 05, 2025, 04:05 PM EDT
-1.22% (1D)
| Bid | 24.2 |
| Market Cap | 2.18B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.74 |
| PE Ratio (ttm) | -34.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 26.5 |
| Volume | 12,596 |
| Avg. Volume (20D) | 56,763 |
| Open | 25.50 |
| Previous Close | 25.48 |
| Day's Range | 25.17 - 25.50 |
| 52-Week Range | 16.50 - 26.50 |
| Beta | 1.00 |
About AAPG
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; A...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 24, 2025
Employees 567
Stock Exchange NASDAQ
Ticker Symbol AAPG
Website https://www.ascentage.cn
1 month ago
+9.96%
Ascentage Pharma Group shares are trading higher a...
Unlock content with
Pro Subscription
